Detalhe da pesquisa
1.
Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statement.
CA Cancer J Clin
; 70(6): 480-504, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32910493
2.
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy.
Blood
; 139(8): 1177-1183, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34797911
3.
A Single Reference Interval for Interpreting Serum Free Light Chains across Patients with Varying Renal Function.
Clin Chem
; 2023 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37147848
4.
NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022.
J Natl Compr Canc Netw
; 20(1): 8-19, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34991075
5.
COVID-19 in Patients with Hematologic Malignancies: Outcomes and Options for Treatments.
Acta Haematol
; 145(3): 244-256, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35134811
6.
A multi-modal diagnostic model improves detection of cardiac amyloidosis among patients with diagnostic confirmation by cardiac biopsy.
Am Heart J
; 232: 137-145, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33212046
7.
Pomalidomide plus low-dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure.
Br J Haematol
; 188(4): 501-510, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31588567
8.
DCEP and bendamustine/prednisone as salvage therapy for quad- and penta-refractory multiple myeloma.
Ann Hematol
; 99(5): 1041-1048, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32130471
9.
Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 18(12): 1685-1717, 2020 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33285522
10.
The effect of donor type on outcomes in adults with acute myeloid leukemia after reduced-intensity hematopoietic peripheral blood cell transplant - a retrospective study.
Transpl Int
; 33(9): 1089-1098, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32468720
11.
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
N Engl J Med
; 375(21): 2023-2036, 2016 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27959731
12.
Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft.
Blood
; 129(19): 2680-2692, 2017 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28292947
13.
NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020.
J Natl Compr Canc Netw
; 17(10): 1154-1165, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31590151
14.
GENESIS: Phase III trial evaluating BL-8040 + G-CSF to mobilize hematopoietic cells for autologous transplant in myeloma.
Future Oncol
; 15(31): 3555-3563, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31495201
15.
Impact of Dose-Adjusted Melphalan in Obese Patients Undergoing Autologous Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(4): 687-693, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29225163
16.
Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma.
Cancer
; 124(22): 4342-4349, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30395359
17.
Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.
Cancer
; 124(4): 816-825, 2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29125192
18.
Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 study.
Br J Haematol
; 182(4): 495-503, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29808907
19.
Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results.
Br J Haematol
; 180(6): 821-830, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29435979
20.
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018.
J Natl Compr Canc Netw
; 16(1): 11-20, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29295877